GlassScriptPhysician profile
Giovanni M Baula
NPI 1699760181
$1,512.62
in general payments reported to CMS, 2019-2025
25 companies · $42.01 in 2025
The $42.01 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $736 · 2020: $532 · 2021: $187 · 2022: $15.15 · 2025: $42.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $42.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $42.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $200.00 | 2020 | |
| Glaxosmithkline, LLC. | $193.19 | 2019-2021 | |
| Amarin Pharma, INC. | $166.94 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $109.01 | 2019 | |
| Acadia Pharmaceuticals INC | $99.45 | 2019 | |
| Pfizer INC. | $90.35 | 2019 | |
| Novartis Pharmaceuticals Corporation | $82.47 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $66.59 | 2019 | |
| Abbvie INC. | $56.52 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $52.00 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $51.73 | 2019-2020 | |
| Nestle Healthcare Nutrition INC. | $41.13 | 2020-2021 | |
| Vivus LLC | $41.03 | 2019 | |
| Esperion Therapeutics, INC. | $35.70 | 2020-2021 | |
| Insmed, INC. | $31.84 | 2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $28.60 | 2019 | |
| Allergan, INC. | $27.89 | 2020 | |
| Arbor Pharmaceuticals, INC. | $25.21 | 2020 | |
| Astellas Pharma US INC | $24.24 | 2020 | |
| Sanofi-Aventis U.S. LLC | $18.46 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.09 | 2020 | |
| Fidia Pharma USA INC. | $15.15 | 2022 | |
| Hikma Pharmaceuticals USA | $14.70 | 2019 | |
| Novo Nordisk INC | $12.96 | 2021 | |
| Lilly USA, LLC | $11.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Giovanni Baula listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.